Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184967
Max Phase: Preclinical
Molecular Formula: C44H76N14O9S2
Molecular Weight: 1009.31
Associated Items:
ID: ALA5184967
Max Phase: Preclinical
Molecular Formula: C44H76N14O9S2
Molecular Weight: 1009.31
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCSSCCN)C(=O)O
Standard InChI: InChI=1S/C44H76N14O9S2/c1-5-26(4)35(40(64)56-32(23-25(2)3)37(61)54-31(42(66)67)16-21-68-69-22-17-45)57-38(62)33(24-27-12-14-28(59)15-13-27)55-39(63)34-11-8-20-58(34)41(65)30(10-7-19-52-44(49)50)53-36(60)29(46)9-6-18-51-43(47)48/h12-15,25-26,29-35,59H,5-11,16-24,45-46H2,1-4H3,(H,53,60)(H,54,61)(H,55,63)(H,56,64)(H,57,62)(H,66,67)(H4,47,48,51)(H4,49,50,52)/t26-,29-,30-,31+,32-,33-,34-,35-/m0/s1
Standard InChI Key: VNHDPTUIKMSTOI-AODXPARNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1009.31 | Molecular Weight (Monoisotopic): 1008.5361 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Einsiedel J, Schmidt MF, Hübner H, Gmeiner P.. (2022) Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors., 61 [PMID:35334449] [10.1016/j.bmc.2022.116720] |
Source(1):